Logo
x

Search category

Subscribe Now

Eccogene

Eccogene Enters into a Collaboration Agreement with AstraZeneca to Develop and Commercialize ECC5004 for Cardiometabolic Diseases

Eccogene Enters into a Collaboration Agreement with AstraZeneca to Develop and Commercialize ECC5004 for Cardiometabolic Diseases

  • November 9, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.